Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Geovax Labs (NQ: GOVX ) 1.110 -0.090 (-7.50%) Streaming Delayed Price Updated: 3:58 PM EDT, Jun 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Geovax Labs < Previous 1 2 3 4 5 Next > GeoVax to Present at BIO International Convention 2024 May 29, 2024 Via TheNewswire.com Exposures COVID-19 GeoVax to Present at BIO International Convention 2024 May 29, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market May 17, 2024 ATLANTA, GA - (NewMediaWire) - May 17, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,... Via TheNewswire.com Topics Regulatory Compliance Exposures Legal Regulatory GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market May 17, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Regulatory Compliance Exposures Legal Regulatory GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 Presented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate Via TheNewswire.com GeoVax to Present Data on GEO-CM04S1, A Next Generation Covid-19 Vaccine, at the World Vaccine Congress March 28, 2024 Via NewMediaWire Exposures COVID-19 GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the 36th Annual Roth Conference March 08, 2024 Via Investor Brand Network Exposures COVID-19 GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System March 06, 2024 Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines Via NewMediaWire GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 May 07, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 May 07, 2024 GeoVax to Host Conference Call at 4:30 PM ET Via TheNewswire.com GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine April 04, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine April 04, 2024 Presentation Made During the 24th Annual World Vaccine Congress Via TheNewswire.com Exposures COVID-19 GeoVax to Present at the 36th Annual Roth Conference March 12, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax Reports 2023 Year-End Financial Results and Provides Business Update February 29, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 February 22, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 February 22, 2024 GeoVax to Host Conference Call at 4:30 PM ET Via TheNewswire.com GeoVax to Present at the 2024 BIO CEO & Investor Conference February 19, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Present at the 2024 BIO CEO & Investor Conference February 19, 2024 ATLANTA, GA - (NewMediaWire) - February 19, 2024 - Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today... Via TheNewswire.com GeoVax Announces Multiple Patent Issuances and Allowances February 13, 2024 Intellectual Property Assets Strengthened for Cancer Immunotherapy Program Via NewMediaWire Topics Intellectual Property Exposures Intellectual Property GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster February 06, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Exposures COVID-19 GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster February 06, 2024 Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants Via TheNewswire.com Exposures COVID-19 GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement January 29, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement January 29, 2024 ATLANTA, GA - (NewMediaWire) - January 29, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today... Via TheNewswire.com GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology January 08, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax Announces Gedeptin Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients January 04, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax Announces Issuance of Malaria Vaccine Patent January 03, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Exposures Intellectual Property GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox December 19, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Intellectual Property Exposures COVID-19 Intellectual Property GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress November 30, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire GeoVax to Participate in Upcoming December Investor Events November 29, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.